Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Postterm Pregnancies
Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks
1 other identifier
observational
227
1 country
1
Brief Summary
Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 9, 2018
CompletedFirst Posted
Study publicly available on registry
October 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedOctober 29, 2019
October 1, 2019
3.1 years
October 9, 2018
October 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Category III fetal heart rate tracings
Absent baseline fetal heart rate variability and any of the following: recurrent late decelerations, recurrent variable decelerations, bradycardia, sinusoidal pattern
24 hours
Secondary Outcomes (4)
Middle cerebral artery pulsatility index
24 hours before delivery
Mean uterine artery pulsatility index
24 hours before delivery
Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio
24 hours before delivery
Oligohydramnios
24 hours before delivery
Study Arms (3)
Cohort
This will be a nested case-control study. Women with low risk pregnancies at or beyond 41 weeks, who will be referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according institutional protocol will constitute the cohort. Then women with intrapartum abnormal fetal heart rate tracings (cases) will be identified and match with controls. The primary outcome will be to obtain odds ratios for the Doppler ultrasound parameters (middle cerebral artery pulsatility index, mean uterine artery pulsatility index and Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio) and Ultrasound assessment of amniotic fluid index that would be associated with intrapartum category III fetal heart rate tracing.
Cases
Cases will be patients with abnormal intrapartum cardiotocogram (category III fetal heart rate tracing). Intervention: Ultrasound and Doppler ultrasound
Controls
Those will be patients with normal intrapartum cardiotocogram (category I fetal heart rate tracing) or category II that converted into category I after intrauterine resuscitation methods. Intervention: Ultrasound and Doppler ultrasound
Interventions
Assessment of fetal cerebral and maternal uterine pulsatility index using Doppler ultrasound. Measurement of amniotic fluid index according to four-quadrant technique.
Eligibility Criteria
Women with low risk late term or postterm pregnancy (at least 41 weeks) with confirm gestational age by first trimester ultrasound examination, who will be referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according institutional protocol.
You may qualify if:
- Singleton pregnancy
- Gestational age of at least 287 days (41 weeks)
- Low risk pregnancy (defined as the absence of maternal or fetal complications other than postterm pregnancy)
You may not qualify if:
- Twin or multiple gestation
- Uncertain gestational age
- Non vertex presentation
- Estimated fetal weight below the 10th percentile for gestational age (Hadlock´s formula)
- Fetal macrosomia (estimated fetal weight ≥ 4 Kilos) diagnosed by clinical measurement (Johnson´s technique) or ultrasound measurement (Hadlock´s formula).
- Fetal abnormalities found on routine anomaly scan.
- Maternal medical disorder (preeclampsia, chronic hypertension, diabetes, lupus, hyperthyroidism)
- Prelabour rupture of membranes
- Antepartum hemorrhage
- Any fetopelvic disproportion that could create dystocia during labor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Dr. José Eleuterio González
Monterrey, Nuevo León, 64460, Mexico
Related Publications (5)
Lebovitz O, Barzilay E, Mazaki-Tovi S, Gat I, Achiron R, Gilboa Y. The clinical value of maternal and fetal Doppler parameters in low-risk postdates pregnancies - a prospective study. J Matern Fetal Neonatal Med. 2018 Nov;31(21):2893-2897. doi: 10.1080/14767058.2017.1359531. Epub 2017 Aug 9.
PMID: 28738721BACKGROUNDLam H, Leung WC, Lee CP, Lao TT. The use of fetal Doppler cerebroplacental blood flow and amniotic fluid volume measurement in the surveillance of postdated pregnancies. Acta Obstet Gynecol Scand. 2005 Sep;84(9):844-8. doi: 10.1111/j.0001-6349.2005.00741.x.
PMID: 16097973BACKGROUNDArabin B, Becker R, Mohnhaupt A, Vollert W, Weitzel HK. Prediction of fetal distress and poor outcome in prolonged pregnancy using Doppler ultrasound and fetal heart rate monitoring combined with stress tests (II). Fetal Diagn Ther. 1994 Jan-Feb;9(1):1-6. doi: 10.1159/000263899.
PMID: 8142046BACKGROUNDTongsong T, Srisomboon J. Amniotic fluid volume as a predictor of fetal distress in postterm pregnancy. Int J Gynaecol Obstet. 1993 Mar;40(3):213-7. doi: 10.1016/0020-7292(93)90833-i.
PMID: 8096472BACKGROUNDAdiga P, Kantharaja I, Hebbar S, Rai L, Guruvare S, Mundkur A. Predictive value of middle cerebral artery to uterine artery pulsatility index ratio in hypertensive disorders of pregnancy. Int J Reprod Med. 2015;2015:614747. doi: 10.1155/2015/614747. Epub 2015 Feb 1.
PMID: 25763408BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Flavio Hernández-Castro, MD PhD
Hospital Universitario Dr. José Eleuterio González UANL
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator Flavio Hernández Castro MD PhD
Study Record Dates
First Submitted
October 9, 2018
First Posted
October 11, 2018
Study Start
January 1, 2016
Primary Completion
February 1, 2019
Study Completion
October 1, 2019
Last Updated
October 29, 2019
Record last verified: 2019-10